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DemyelinationEpstein–Barr virus-induced gene 3 (EBI3) associates with p28 and p35 to form the immunomodulatory cyto-
kines IL-27 and IL-35, respectively. Infection of EBI3−/− mice with the neuroadapted JHM strain of mouse
hepatitis virus (JHMV) resulted in increased mortality that was not associated with impaired ability to con-
trol viral replication but enhanced T cell and macrophage infiltration into the CNS. IFN-γ secretion from
virus-specific CD4+ and CD8+ T cells isolated from infected EBI3−/−mice was augmented while IL-10 ex-
pression muted in comparison to infected WT mice. These data demonstrate a regulatory role for
EBI3-associated cytokines in controlling host responses following CNS viral infection.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Inoculation of the neurotropic JHM strain of mouse hepatitis virus
(JHMV) into the CNS of susceptible strains of mice provides an excel-
lent model in which to examine host response mechanisms responsi-
ble for both control of viral replication within distinct cell lineages
present in the brain as well as host-derived factors regulating
neuroinflammation (Bergmann et al., 2006). JHMV infection results
in an acute encephalomyelitis characterized by wide-spread replica-
tion primarily in astrocytes and oligodendrocytes with relatively
few neurons being infected (Knobler et al., 1981; Buchmeier and
Lane, 1999; Parra et al., 1999; Perlman et al., 1999; Bergmann et al.,
2006). Control of viral replication during acute disease relies on
virus-specific CD8+ T cells, which function by two different effector
mechanisms within the CNS: IFN-γ secretion is responsible for con-
trolling viral replication in oligodendrocytes whereas a perforin-
dependent mechanism promotes viral clearance from astrocytes
(Lin et al., 1997; Parra et al., 1999). Infiltrating CD4+ T cells provide
a supporting role for the maintenance and expansion of CTLs withiniology & Biochemistry, Multiple
ne 92697-3900, United States.
University School of Medicine,
l rights reserved.the CNS, as well as enhancing effector responses (Stohlman et al.,
1998; Phares et al., 2012). Although a robust cell-mediated immune
response occurs during acute disease, sterilizing immunity is not
achieved, resulting in viral persistence (Stohlman and Weiner,
1981). Histological features associated with viral persistence include
the development of an immune-mediated demyelinating disease
with both T cells and macrophages being important in amplifying dis-
ease severity by contributing to myelin damage (Cheever et al., 1949;
Perlman et al., 1999; Lane et al., 2000; Pewe and Perlman, 2002; Pewe
et al., 2002).
EBV-induced gene-3 (EBI3) encodes a 34 kDa protein that is sim-
ilar to the p40 subunit of IL-12 (Collison and Vignali, 2008; Wojno
and Hunter, 2012). EBI3 is capable of binding subunits p28 or p35
(a subunit of IL-12) to form the cytokines IL-27 and IL-35, respective-
ly (Collison and Vignali, 2008; Wojno and Hunter, 2012). Both IL-27
and IL-35 have important immunoregulatory roles controlling cyto-
kine secretion and inflammation (Collison and Vignali, 2008;
Yoshida and Miyazaki, 2008; Wojno and Hunter, 2012). Recent stud-
ies have highlighted that genetic ablation of EBI3 results in altered T
cell-mediated cytokine expression (Yang et al., 2008) associated
with increased inflammation as well as changes in the composition
of the cellular infiltrate in experimental models of delayed-type hy-
persensitivity (Tong et al., 2010), autoimmune inflammation (Igawa
et al., 2009; Liu et al., 2012), as well as hepatitis (Siebler et al.,
2008). The influence of EBI3 in host defense in response to infection
with a neurotropic virus has not been well characterized and was
the focus of the present study.
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2.1. Virus and mice
EBI3−/− mice (on the C57BL/6, H-2b background) were generat-
ed as previously described (Yang et al., 2008) and generously provid-
ed by Centecor. Age-matched EBI3−/− or C57BL/6 control mice
(C57BL/6, H-2b, National Cancer Institute, Frederick, MD) were used
at 5–8 weeks of age for all experiments. For CNS infection studies,
mice were intracranially (i.c.) injected with 250 plaque forming
units (PFU) of MHV strain J2.2v-1 (JHMV) suspended in 30 μL of ster-
ile HBSS. Animals were sacrificed at defined time points and one-half
of each brain at each time point was used for plaque assay on a mouse
astrocytoma cell line (Hirano et al., 1978; Lane et al., 2000; Liu et al.,
2000; Held et al., 2008). For systemic MHV infection, mice were intra-
peritoneally (i.p.) injected with 2.5×105 PFU of MHV strain DM
suspended in 500 μL HBSS. Control (sham) mice were injected with
sterile HBSS alone. All experiments were approved by the University
of California, Irvine Institutional Animal Care and Use Committee.2.2. Flow cytometry
Mononuclear cells were obtained from tissues (brains and
spleens) at defined times post-infection with JHMV using previously
described methods (Lane et al., 2000; Stiles et al., 2006; Held et al.,
2008). In brief, single cell suspensions of experimental tissues (all de-
pleted of red blood cells) were stained with combinations of anti-
bodies directed against the following surface markers: CD4, CD8a,
CD44, CD25, CD62L, IA-IE (BD Biosciences), CD45 (eBiosciences),
and F4/80 (Ab Direct). In all cases, isotype-matched control anti-
bodies were used. Virus-specific CD4+ and CD8+ T cells recognizing
their respective immunodominant epitope between amino acids 133
and 147 of the membrane (M) glycoprotein (M133–147) and surface
(S) glycoprotein (S510–518) were determined by intracellular IFN-γ
staining using previously described methods (Glass et al., 2002;
Glass and Lane, 2003). The presence of virus-specific CD8+ T cells
was also evaluated using S510–518 MHC class I tetramers as previ-
ously described (Stiles et al., 2006). Frequency data are presented as
the percentage of positive cells within the gated population. Total
cell numbers were calculated by multiplying these values by the
total number of live cells isolated.2.3. Quantitative real-time PCR
Total RNA from brains of experimental mice was extracted in Trizol
(Invitrogen, Carlsbad, CA) and purified from infected EBI3−/− and WT
mice as well as sham-infected mice (Ambion). cDNA synthesis was
performed using Superscript VILO cDNA Synthesis Kit (Invitrogen).
Real-Time PCR analysis was completed using a LightCycler 480 Instru-
ment II (Roche). IL-10mRNA levelswere assessed using specific primers:
forward primer — AGCCGGGAAGACAATAACTG; reverse primer —
GGAGTCGGTTAGCAGTATGTTG. Amplicon expression was normalized
to GAPDH (Invitrogen). LightCycler 480 SYBR Green I Master (Roche)
was used in all reactionswith the following assay conditions: 10 min ini-
tial denaturation at 95 °C, and 45 cycles of 30 s at 95 °C and 1 min at
60 °C. Data were analyzed using LightCycler 480 software (Roche).2.4. Ex vivo cytokine production
C57BL/6 mice were injected via i.p. with 2.5×105PFU of MHV
strain DM suspended in 500 μL HBSS. Mice were sacrificed at day
7 p.i. and splenocytes stimulated with 5 μM OVA, M133, or S510 pep-
tides for 48 h were collected and determined for IL-10 and IFN-γ se-
cretion using the respective R&D DuoSet ELISA kits.2.5. CTL assay
Spleen-derived CD8+ T cells were analyzed for lytic activity at
day 7 following i.p. infection of WT and EBI3−/− mice with
2.5×105 PFU of the DM strain of MHV. Numbers of S510–518-specific
CD8+ T cells were determined by intracellular IFN-γ staining follow-
ing exposure to the S510–518 peptide. CTL assays were performed
with RMA-s (H-2b) target cells preincubated with 5 μM S510–518
peptide or OVA peptide as a control that were combined with immune
CD8+ T cells at various effector:target ratios. Amounts of lactate dehy-
drogenase (LDH) released from lysed cells were determined by using a
CytoTox 96® Non-Radioactive Cytotoxicity Assay (Promega, Madison,
WI). Percentage lysis was determined as specified by manufacturer's
protocols. Percentage lysis of OVA peptide-pulsed co-cultures was
subtracted from the percentage lysis of S510–518 pulsed co-cultures
to eliminate background CTL activity.
2.6. Histology and immunohistochemistry
Brains and spinal cords from experimental mice were harvested
from PBS-perfused mice and fixed in 4% paraformaldehyde overnight.
Brain tissues were embedded in paraffin and stained with hematoxylin
and eosin (H&E). Spinal cordswerefixed in normal balance formalin for
24 h and then embedded in paraffin. Sections of spinal cords were
stained with luxol fast blue (LFB) to identify myelin (blue) and
counterstained with Harrison hematoxylin and eosin to visualized
cellular inflammation (Lane et al., 2000; Liu et al., 2001). Rabbit anti-
mouse GFAP (Invitrogen, Carlsbad, CA) (1:500 dilution in phosphate-
buffered saline containing 10% normal rabbit serum [NRS]) used for de-
tection of activated astrocytes. A biotinylated secondary antibody
(1:400 dilution, Vector Laboratories, Burlingame, CA) was used for de-
tection. Staining was performed on 6 μm-thick frozen sections fixed
with 4% paraformaldehyde. The ABC Elite (Vector Laboratories) staining
system was used according to the manufacturer's instructions, and
diaminobenzidine (DAB) was used as a chromogen. All slides were
counterstained with hematoxylin, dehydrated, and mounted. Staining
controls were (i) omission of primary antibodies from the staining se-
quence and (ii) treatment of sham-infectedmicewith primary and sec-
ondary antibodies.
2.7. Statistical analysis
2-Tailed unpaired Student's T-test was conducted to determine
statistical significance for all assays.
3. Results
3.1. Survival and histopathology
Wildtype (WT) and EBI3−/−micewere infected intracranially (i.c.)
with 250 PFU of JHMV to evaluate the contributions of EBI3 in host de-
fense. Genetic ablation of EBI3 signaling was associated with increased
(p≤0.01) susceptibility to JHMV-induced death with ~70% of infected
EBI3−/− mice dying by day 12 p.i. whereas only ~30% of WT mice
died (Fig. 1A). Examination of brains of JHMV-infected mice revealed
that EBI3−/− mice displayed overall increased thickening of the me-
ninges as well as increased perivascular cuffing when compared to
infected WT mice indicating enhanced neuroinflammation in response
to JHMV infection in the absence of EBI3 expression (Fig. 1B). Addition-
ally, increased astrogliosis, as determined byGFAP staining,was evident
in JHMV-infected EBI3−/−mice in comparison to WT mice (Fig. 1C).
3.2. CNS viral titers and neuroinflammation
To determine if increased death was the result of an inability to con-
trol viral replication, viral titers within the brains of infected WT and
Fig. 1. Mortality and neuroinflammation following JHMV infection of the CNS. (A) WT and EBI3−/− mice were infected i.c. with 250 PFU of JHMV and survival determined. Data
presented is representative of 3 independent experiments with a minimum of 6 mice/experiment. (B) Representative H&E staining showing increased perivascular cuffing (top
panels) and increased meningeal inflammation in the brains of JHMV-infected WT and EBI3−/−mice at day 7 p.i. (C) Representative GFAP staining showing increased astrogliosis
within the brains of JHMV-infected EBI3−/− mice compared to WT mice at day 7 p.i.
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were present within the brains of bothWT and EBI3−/−mice at day 5
p.i. By day 7 p.i., EBI3−/− mice displayed elevated titers (p≤0.05)
compared to WT mice yet both groups of mice reduced titers below
the level of detection (~100 PFU/g tissue) at day 12 p.i. Flow analysis
of T cell infiltration into the CNS of infected animals revealed reduced
(p≤0.05) numbers of CD4+ and CD8+ T cells present within the
brains of infected EBI3−/− mice compared to WT mice at day 5 p.i.
(Fig. 2B). However, by day 7 p.i., there were increased numbers of
CD8+ T cells present in the CNS of infected EBI3−/− mice compared
to WT mice and this was sustained out to day 12 p.i. (Fig. 2B). In con-
trast, there were no differences in numbers of inflammatory CD4+ T
cells within the CNS of infected WT and EBI3−/− mice at days 7 and
12 p.i. (Fig. 2B). Further examination revealed enhanced activation
(CD62L−CD25+) states in both CD4+andCD8+T cell (Fig. 2C) subsets
present within the CNS of JHMV-infected EBI3−/− mice compared to
WT mice. Macrophage (CD45highF4/80+) infiltration, as determined
by flow cytometric analysis, was elevated in infected EBI3−/−mice at
days 7 (p≤0.05) and 12 p.i. (p≤0.01) when compared to infected WT
mice (Fig. 3A). In addition, flow analysis revealed increased (p≤0.05)
MHC class II expression on activated microglia at days 7 and 12 p.i.
suggesting increased IFN-γ levels within the CNS of JHMV-infected
EBI3−/− mice when compared to infected WT mice (Fig. 3B). Earlier
studies indicate that the absence of EBI3 alters the immunomodulatory
cytokine IL-10 levels in models of inflammation (Zahn et al., 2005;
Hausding et al., 2007; Tong et al., 2010). In accordancewith these earlier
studies, we detected significantly (p≤0.01) lower levels of mRNA tran-
scripts specific for IL-10 within the brains of infected EBI3−/− mice
compared to WT mice (Fig. 3C). Evaluation of demyelination revealed
comparable levels of white matter damage in both infected EBI3−/−
and WT mice (Fig. 3D).3.3. Virus-specific T cells
Intracellular IFN-γ staining in response to defined CD4 [Matrix (M)
protein spanning epitopes 133–144] and CD8 [Spike (S) glycoproteinspanning epitopes 510–518] viral epitopes was employed to measure
infiltration of virus-specific T cells into the CNS of JHMV-infected
mice. Analysis at day 7 p.i. revealed reduced (pb0.05) numbers of
M133–144-specific CD4+ T cells in the brains of infected EBI3−/−
mice compared to WT mice while infiltration of S510–518-specific
CD8+ T cells was significantly (pb0.05) increased in EBI3−/− mice
compared to WT mice (Fig. 4A and B). S510–518 MHC class I tetramer
staining confirmed increased numbers (p≤0.05) of virus-specific
CD8+ T cells within the CNS of EBI3−/−mice when compared to WT
mice (Fig. 4C). By day 12 p.i., there were increased (p≤0.001) numbers
of virus-specific CD4+ and CD8+ T cells present in the brains of
EBI3−/− mice compared to WT mice (not shown). To determine if
CTL activity was influenced by loss of EBI3 expression, ex vivo CTL as-
says were performed. WT and EBI3−/− mice were infected i.p. with
MHV and spleens were removed at day 7 p.i. Similar frequencies of
virus-specific CD8+ T cells were present within the spleens of infected
WT and EBI3−/−mice as determined by intracellular IFN-γ staining in
response to S510–518 as well as S510–518 MHC class I tetramer
staining (not shown). As shown in Fig. 4D, CTL activity is slightly
muted at all E:T ratios tested arguing for a potential role for EBI3 in
augmenting CTL activity.3.4. T cell cytokine production
We next interrogated how genetic ablation of EBI3 influenced T
cell responses following JHMV infection. Both WT and EBI3−/−
mice were challenged by i.p. injection with virus and splenocytes iso-
lated at day 7 p.i. Intracellular IFN-γ staining demonstrated decreased
(p≤0.05) numbers of M133–147-specific CD4+ T cells isolated from
the spleens of EBI3−/− mice compared to WT mice while compara-
ble numbers of S510–518-positive CD8+ T cells were present in
both WT and EBI3−/−mice (Fig. 5A). Cultured T cells were stimulat-
ed with either M133–147 or S510–518 and IFN-γ levels determined
by ELISA. As shown in Fig. 5B, T cells from EBI3−/− mice produced
significantly more IFN-γ in response to peptide stimulation in com-
parison to WT mice. There was a ~2-fold increase (p≤0.05) in IFN-γ
Fig. 2. Brain viral titers and T cell infiltration. (A) WT and EBI3−/− mice were i.c. infected with 250 PFU of JHMV and viral titers determined at days 5, 7, and 12 p.i. (B) T cell in-
filtration into the CNS of JHMV-infected mice was determined by flow cytometry at days 5, 7, and 12 p.i. (C) Activation status of T cells was determined by measuring CD62L and
CD25 expression on T cells infiltrating into the CNS of JHMV-infected mice by flow cytometry. Representative dot blots are shown for CD4+ T cells and CD8+ T cells; and the overall
increase in CD62LloCD25hi CD4+ and CD8+ T cell subsets in infected EBI3−/− mice compared to WT mice is shown. For all experiments, data is representative of 2 independent
experiments with a minimum of 3 mice per time point; data is presented as average±SEM; * indicates p≤0.05.
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while IFN-γ levelswere increased>2.5-fold (p≤0.01) by S510–518-spe-
cific CD8+T cells isolated from EBI3−/−mice. In addition, IL-10 produc-
tion was significantly (p≤0.05) reduced in antigen-stimulated virus-
specific EBI3−/− T cells compared to WT cells (Fig. 5C).
4. Discussion
In this study, we demonstrate that EBI3 plays an important role in
controlling neuroinflammation and T cell responses in response to
JHMV infection of the CNS. Specifically, JHMV infection of EBI3-
deficient mice increased mortality during the acute stage of the disease
and this is not the result of impaired ability to control viral replication.
Rather, increased disease severity was associated with enhanced leuko-
cyte entry into the CNS with greater numbers of both CD8+ T cells and
virus-specific CD8+ T cells when compared to WT mice. In addition,
IFN-γ secretion was increased following viral peptide stimulation of
EBI3-deficient CD4+ and CD8+ T cells isolated from JHMV-infectedmice. Although IFN-γ production was elevated in CD8+ T cells, CTL ac-
tivity was muted indicating differential roles for EBI3 in contributing to
antiviral effector functions. These findings highlight that within the
context of JHMV infection of the CNS, EBI3 is important in influencing
virus-specific CD8+ T cell effector function yet the overall impact of
how this contributes to increased mortality remains enigmatic and re-
quires continued investigation.
Previous studies indicate that genetic ablation of EBI3 influences
cytokine production by T cells. For example, delayed-type hypersen-
sitivity is dramatically exacerbated in EBI3−/− associated with en-
hanced infiltration of inflammatory cells into the footpad of
antigen-challenged mice as compared to control animals (Tong et
al., 2010). In addition, EBI3 negatively regulates T cell production of
IL-17 and IL-22 and this correlated with enhanced expression of the
transcription factor RORgT (Yang et al., 2008). Experimental infection
of EBI3-deficient mice with Leishmania demonstrated muted Th1 re-
sponses indicating a potential role in regulating immune responses
following microbial infection (Zahn et al., 2005). The majority of
Fig. 3.Macrophage infiltration and demyelination. (A) Macrophage (CD45highF480+) infiltration into the CNS of infected mice was determined at days 5, 7, and 12 p.i. by flow cy-
tometry. (B) MHC class II expression on resident microglia (CD45loF480+) from infected EBI3−/− andWTmice was determined at days 5, 7, and 12 p.i. by flow cytometry. Data for
A and B is derived from 2 independent experiments with a minimum of 3 mice per time point; data is presented as average+SEM and * indicates p≤0.05. (C) Expression of mRNA
transcripts specific for IL-10 within the brains of JHMV-infected EBI3−/− and WT mice at day 7 p.i. was performed by qPCR analysis. Data is derived from 4 mice from each exper-
imental group and presented as average±SEM fold change compared to sham-infected mice; ** indicates p≤0.01. (D) Representative spinal cord sections from JHMV-infected
EBI3−/− and WT mice isolated at day 12 p.i. and stained with luxol fast blue to assess the severity of demyelination (areas of white matter pathology are outlined by hashmarks).
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have characterized a role within the context of IL-27 (EBI3/p28) signal-
ing. These studies have highlighted an important role for IL-27 in mod-
ulating T cell as well as inflammatory responses. IL-27 signals through a
heterodimeric receptor consisting of IL-27Ra (WX1) and gp130 (Pflanz
et al., 2004). Originally characterized as a proinflammatory cytokine
that was necessary for initiation of Th1 differentiation (Pflanz et al.,
2002), IL-27 expression was shown to be critical in generation of pro-
tective T cell responses in response to infection with Leishmania major
(Zahn et al., 2005). However, additional studies have shown that loss
of IL-27 signaling through genetic ablation of either EBI3 or IL27Ra
does not diminish the ability to generate a protective Th1 response
(Batten and Ghilardi, 2007). Rather, animals lacking these genes have
exhibited enhanced immune responses associated with accelerated tis-
sue damage that correlates with elevated levels of proinflammatory cy-
tokines including IFN-γ following infection with Toxoplamsa gondii and
Mycobacterium tuberculosis (Villarino et al., 2003; Holscher et al., 2005).
With regard to viral infection, IL-27 has been shown to exert an
anti-viral effect on HIV and evidence suggests that this is mediated, in
part, by activating multiple interferon-inducible genes (Fakruddin et
al., 2007; Imamichi et al., 2008).
Whether increased neuroinflammation and IFN-γ secretion by T
cells in response to JHMV infection of the CNS is due to impaired signal-
ing through either IL-27 or IL-35 remains to be determined. However, a
recent study by Liu et al. (2012) examined the influence of EBI3 within
the context of experimental autoimmune encephalomyelitis (EAE), an
autoimmune model of neuroinflammation and demyelination. Similar
to our findings, there was increased neuroinflammation in MOG-
immunized EBI3−/− mice compared to WT controls and this wasaccompanied by increased Th1 responses (Liu et al., 2012). However,
production of IFN-γ was not affected in EBI3−/− mice but IL-2 and
IL-17 levels were dramatically elevated. Although neuroinflammation
was increased in EBI3−/− mice with EAE, the severity of disease was
onlymarginally enhanced compared toWTmice and thismay be the re-
sult of increased numbers of CD4+Foxp3+Treg's that exhibited potent
suppressive functions (Liu et al., 2012). IL-17-producing T cells are not
detected within the CNS of JHMV-infected mice so it is unlikely that
the absence of EBI3 affects secretion of IL-17 in this model (Held et al.,
2008; Kapil et al., 2009). Whether Tregs are increased in number and/
or exhibit enhanced suppressor functions in response to JHMV infection
of EBI3−/−mice is unknown at this time. It is interesting to speculate
that a reason that the severity of demyelination is not dramatically
increased in JHMV-infected EBI3−/− mice compared to WT mice
even in the face of increased neuroinflammation may be the result of
enhanced suppressor activity by Tregs and this is currently under
investigation.
Our findings that EBI3 deficiency increases IFN-γ secretion are
consistent with other studies examining how EBI3/IL-27 controls T
cell responses following microbial infection (Villarino et al., 2003;
Stumhofer et al., 2006). Moreover, a recent study by Stumhofer et
al. (2006) has demonstrated enhanced anti-tumor responses by
CD8+ T cells in EBI3−/− mice associated with increased IFN-γ pro-
duction. Therefore, loss of EBI3 expression is not restricted to altered
effector functions in CD4+ T cell subsets but can also include CD8+ T
cell subsets. An important question that remains to be resolved is
whether the change in disease course and T cell responses in
JHMV-infected EBI3−/− mice reflects deficiencies in IL-27 or IL-35
expression.
Fig. 4. Anti-viral T cell responses. WT and EBI3−/−mice were i.c. infected with 250 PFU of JHMV and generation of virus-specific T cells measured by intracellular IFN-γ staining in
response to the CD4+ T cell epitope M133–147 and CD8+ T cell epitope S510–518. As controls, ovalbumin (OVA) peptides corresponding to defined CD4+ and CD8+ T cell sub-
sets were also included. (A) Representative dot blots showing increased IFN-γ staining in CD4+ and CD8+ T cell subsets in infected EBI3−/−mice compared to WT mice at day 7
p.i. (B) Quantification of intracellular IFN-γ expression in response to viral peptides reveals increased frequencies of virus-specific CD4+ and CD8+ T cells within the brains of
JHMV-infected EBI3−/− mice compared to WT mice. (C) Staining with the S510–518-MHC class I tetramer reveals increased staining within the brains of infected EBI3−/−
mice compared toWTmice at day 7 p.i. Data in B and C is derived from 2 independent experiments with a minimum of 3 mice per group and presented as average±SEM; * indicates
pb0.05 (D) WT and EBI3−/− mice were infected i.p. with JHMV and splenocytes removed at day 7 p.i. CTL activity to S510–518-pulsed target cells was performed as previously
described (Stiles et al., 2006) using different E:T ratios and * indicates p≤0.05.
Fig. 5. T cell cytokine production. WT and EBI3−/−mice were injected i.p. with JHMV and splenocytes isolated at day 7 p.i. to evaluate expression of IFN-γ and IL-10 in response to
viral peptide stimulation. (A) Intracellular IFN-γ staining reveals diminished frequency of M133–147-specific CD4+ T cells in EBI3−/−mice compared to WT whereas there were
similar frequencies of virus-specific CD8+ T cells. Splenocytes from infected WT and EBI3−/− mice were stimulated with either 5 μM M133–147 or S510–518 peptides for 48 h
and secretion of IFN-γ (B) or IL-10 (C) determined by ELISA. * indicates p≤0.05 and ** indicates p≤0.01.
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